{"id":"NCT02938585","sponsor":"Novo Nordisk A/S","briefTitle":"Efficacy and Safety of Turoctocog Alfa for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Chinese Patients With Haemophilia A","officialTitle":"Efficacy and Safety of Turoctocog Alfa for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Chinese Patients With Haemophilia A","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-12-12","primaryCompletion":"2018-03-16","completion":"2018-12-12","firstPosted":"2016-10-19","resultsPosted":"2019-08-26","lastUpdate":"2020-07-27"},"enrollment":68,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Congenital Bleeding Disorder","Haemophilia A"],"interventions":[{"type":"DRUG","name":"turoctocog alfa","otherNames":[]},{"type":"DRUG","name":"turoctocog alfa","otherNames":[]}],"arms":[{"label":"Prophylactic treatment","type":"EXPERIMENTAL"},{"label":"On-demand treatment","type":"EXPERIMENTAL"}],"summary":"This trial is conducted in China. The aim of this trial is to evaluate the clinical efficacy of turoctocog alfa in treatment of bleeding episodes in Chinese patients with severe haemophilia A (FVIIIâ‰¤1%).","primaryOutcome":{"measure":"Haemostatic Effect of Turoctocog Alfa (Treatment of Bleeds): 6 Months","timeFrame":"Month 0-6","effectByArm":[{"arm":"Small Children (0 to <6 Years)","deltaMin":35,"sd":null},{"arm":"Older Children (6 to <12 Years)","deltaMin":156,"sd":null},{"arm":"Adolescents (12 to <18 Years)","deltaMin":20,"sd":null},{"arm":"Adults (>=18 Years)","deltaMin":190,"sd":null}],"pValues":[]},"eligibility":{"minAge":null,"sex":"MALE","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":2},"locations":{"siteCount":11,"countries":["China"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":9},"commonTop":["Upper respiratory tract infection","Nasopharyngitis","Pyrexia","Diarrhoea","Cough"]}}